While above average or high BMI (Body Mass Index) is often linked to cancers diabetes cardiovascular and other diseases in some cases the higher level of BMI can improve the chance of survival among certain cancers suggests new research. Focusing on clinical trials of atezolizumab a common immunotherapy treatment for non-small-cell lung cancer (NSCLC) the Australian cancer researchers found improved responsiveness to the drug in those with a high body mass index (BMI). The results of the research were published in the journal JAMA Oncology. The study contrast with regular warnings about the health risks of patients who are overweight